CHEN Yuan-hong, WANG Wan-mei, WANG Hao, LI Hong-yan. Comparison of esomeprazole- and omeprazole-based triple therapy regimens for duodenal ulcer with Helicobacter pylori infection[J]. Journal of Southern Medical University, 2005, 25(08): 1045-1047.
[1] 中华医学会消化病学分会.幽门螺杆菌共识意见(2003.安微桐城)[J].中华消化杂志,2004,24(2):126-7. [2] Thitiphuree S, Talley NJ. Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy[J]. Int J Clin Praet, 2000, 54(8): 537-41. [3] 崔岚,袁静,杨惠娣.艾司奥美拉唑[J].中国新药杂志,2001,10(3):170-12. [4] 李晓宇,胡伏莲.幽门螺杆菌感染治疗的研究进展[J].中国新药杂志,2002,11(6):443-6. [5] Rohss K, Hasselgren G, Hedenstrom H. Effect of esomeprazole 40mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease[J]. Dig Dis Sci, 2002,47: 954-8. [6] Laine L, Fenneety MB, Osto M, et al. Esomeprazeole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials[J].Am J Gastroenterol, 2000, 95(12): 3393-8.